4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-048746
President and CEO sold 34,196 shares at an average $21.09 ($721,236)
- President and CEO acquired 34,196 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall President and CEO | 2022-09-01 | Option exercise | +17,100 | $2.90 | $49,535 | 198,250 | D: show line 1 in the form |
| Fordyce Marshall President and CEO | 2022-09-01 | Sale | −17,100 | $21.22 | $362,783 | 181,150 | D: show line 2 in the form |
| Fordyce Marshall President and CEO | 2022-09-02 | Option exercise | +7,346 | $2.90 | $21,280 | 188,496 | D: show line 3 in the form |
| Fordyce Marshall President and CEO | 2022-09-02 | Sale | −7,346 | $20.26 | $148,863 | 181,150 | D: show line 4 in the form |
| Fordyce Marshall President and CEO | 2022-09-02 | Option exercise | +9,750 | $2.90 | $28,244 | 190,900 | D: show line 5 in the form |
| Fordyce Marshall President and CEO | 2022-09-02 | Sale | −9,750 | $21.50 | $209,590 | 181,150 | D: show line 6 in the form |
| Open-market sales · 34,196 sh · avg $21.09 · $721,236 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall President and CEO | 2022-09-01 | Option exercise · Stock Option (right to buy) | −17,100 | 1,073,012 | D: show line 7 in the form | ||
| Fordyce Marshall President and CEO | 2022-09-02 | Option exercise · Stock Option (Right to Buy) | −17,096 | 1,055,916 | D: show line 8 in the form |
Loading xslF345X03/doc4.xml…